Literature DB >> 27365028

[Molecular physical medicine in rheumatic disease patterns].

U Lange1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27365028     DOI: 10.1007/s00393-016-0116-0

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


× No keyword cloud information.
  7 in total

1.  [Molecular physical medicine].

Authors:  U Lange
Journal:  Z Rheumatol       Date:  2012-07       Impact factor: 1.372

Review 2.  Balneotherapy in rheumatic diseases--an overview of novel and known aspects.

Authors:  U Lange; U Müller-Ladner; K L Schmidt
Journal:  Rheumatol Int       Date:  2005-07-12       Impact factor: 2.631

3.  Efficacy of intensive physiotherapy in combination with low-dose etanercept in active spondyloarthritis: a monocentric pilot study.

Authors:  Florian M P Meier; Ulf Müller-Ladner; Uwe Lange
Journal:  J Rheumatol       Date:  2014-09       Impact factor: 4.666

4.  The effect of mild whole-body hyperthermia on systemic levels of TNF-alpha, IL-1beta, and IL-6 in patients with ankylosing spondylitis.

Authors:  Ingo H Tarner; Ulf Müller-Ladner; Christine Uhlemann; Uwe Lange
Journal:  Clin Rheumatol       Date:  2008-12-17       Impact factor: 2.980

5.  [Serial whole-body cryotherapy in the criostream for inflammatory rheumatic diseases. A pilot study].

Authors:  Uwe Lange; Christine Uhlemann; Ulf Müller-Ladner
Journal:  Med Klin (Munich)       Date:  2008-06-15

Review 6.  Heat, cold and inflammation.

Authors:  K L Schmidt; V R Ott; G Röcher; H Schaller
Journal:  Z Rheumatol       Date:  1979 Nov-Dec       Impact factor: 1.372

7.  Effects of in vitro hyperthermia on proliferative responses and lymphocyte activity.

Authors:  Y H Huang; A Haegerstrand; J Frostegård
Journal:  Clin Exp Immunol       Date:  1996-01       Impact factor: 4.330

  7 in total
  1 in total

1.  [Therapeutic effects of complex multimodal rheumatologic treatment in the Rheumatology Center, Rhineland-Palatinate].

Authors:  K Triantafyllias; C Sauer; A Schwarting
Journal:  Z Rheumatol       Date:  2022-05-09       Impact factor: 1.530

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.